Bloomberg
8VC's Lonsdale on Health Tech, VC and Immigration
May.11 -- Joe Lonsdale, 8VC founding partner and Palantir Technologies founder, discusses technology's impact on health care, the state of the VC market and U.S. immigration policy. He speaks with Bloomberg's Mike McKee on "What'd You...
Bloomberg
Stick With China’s Largest Pharma Guys, Says Citigroup’s Yung
Jul.23 -- John Yung, head of Asia healthcare research at Citigroup, discusses China’s healthcare sector, the possibility of an expansion to the drug procurement program, consolidation and his outlook for the industry. He speaks on...
Bloomberg
Avantor Wants to Bring Vaccine to Market in Record Time: CEO
Nov.18 -- Avantor President and Chief Executive Officer Michael Stubblefield discusses the company's role in the fight against the Covid-19 pandemic with Bloomberg's Vonnie Quinn on "Bloomberg Markets."
Bloomberg
PGIM CEO Hunt Says It's a Great Time to Be an Active Investor
Mar.26 -- PGIM CEO David Hunt sees investment opportunities in private credit and health sciences. He speaks with Bloomberg's David Westin on "Balance of Power."
Bloomberg
Which Vaccine Has the Highest Efficacy Against Delta?
Jul.19 -- Ben Cowling, professor of infectious disease epidemiology at the University of Hong Kong's School of Public Health who advises the government on the vaccination process, discusses vaccine efficacies. He also talks about his...
Bloomberg
Nasdaq Biotech Index on Pace for Biggest Gain in 6 Weeks
Bloomberg's Abigail Doolittle takes a look at the performance of pharmaceutical stocks. She speaks on "Bloomberg Markets." (Source: Bloomberg)
Bloomberg
Alexandria Real Estate Equities CEO on Biotech Campuses
Oct.20 -- Joel Marcus, Alexandria Real Estate Equities chief executive officer, discusses developing medical campuses. He speaks with Bloomberg's Erik Schatzker at the Robin Hood Investors Conference in New York.
Bloomberg
Qiming Ventures Sees More U.S. Entrepreneurs in China
Nov.21 -- Nisa Leung, managing partner at Qiming Venture Partners, discusses healthcare innovation in China, biotech and her investment strategy. She speaks exclusively on “Bloomberg Markets: Asia” from the sidelines of Bloomberg's New...
Bloomberg
Defiance ETFs CIO on 2021 Market Expectation
Dec.23 -- Defiance ETFs CIO Sylvia Jablonski discusses the market expectation in 2021. She speaks with Shery Ahn and Paul Allen on "Bloomberg Daybreak: Asia."
Bloomberg
Bring Health to Your Portfolio With Pharma ETFs
July 1 -- Bloomberg Intelligence's Eric Balchunas examines investment opportunities in pharma ETFs. He speaks on "Bloomberg Markets."
Bloomberg
Why Are Market Bulls Shrugging Off Geopolitical Events?
July 21 -- Lew Piantedosi, Eaton Vance portfolio manager, discusses the performance of global stocks with Bloomberg's Vonnie Quinn and David Gura on "Bloomberg Markets."
Bloomberg
Qiming Venture's Kuang Likes Healthcare, Bio Tech
Jun.25 -- As part of our Venture China series, Qiming Venture Partners founding partner Duane Kuang told Bloomberg's Tom Mackenzie where he sees opportunities.
Bloomberg
What to Watch in U.S. Stocks Ahead of Earnings Season
Jul.11 -- David Keller, Sierra Alpha Research chief strategist, takes a look at the performance of markets just ahead of the U.S. corporate earnings season. He speaks with Bloomberg's Abigail Doolittle on "What'd You Miss?"
Bloomberg
Bloomberg Market Wrap 11/22: Trade Optimism, Biotech Hits 52-Week High
Nov.22 -- Bloomberg market reporters take a deep dive into all of today's action.
Bloomberg
Centene Will See Some 'Choppiness' This Quarter Due to Virus, CEO Says
Mar.12 -- Michael Neidorff, Centene Corp. chief executive officer, discusses the impact of the coronavirus outbreak on the company's earnings with Bloomberg's Romaine Bostick and Scarlet Fu on "Bloomberg Markets: The Close."
Curated Video
U.K. Readies For Vaccination Rollout
The United Kingdom will administer the first doses of a COVID-19 vaccine on Tuesday.
Bloomberg
Donald Trump's Election Win Has Big Impact on ETFs
Nov. 11 -- Bloomberg's Eric Balchunas reports on the performance of ETFs after Donald Trump's U.S. election win. Balchunas speaks on "Bloomberg Markets."
Bloomberg
Sanofi Said to Step in on Actelion as J&J Walks Away
Dec.14 -- Sanofi is reported to be in discussion with Actelion after Johnson & Johnson's abandoned its pursuit of the Swiss drugmaker. Bloomberg's Manuel Baigorri reports on "Bloomberg Markets."
Bloomberg
Why the GE-Danaher Deal Is a Win-Win for Both Companies
Feb.25 -- Deane Dray, RBC Capital Markets senior multi-industry and electrical equipment analyst, discusses the sale of General Electric Co.'s bio-pharmaceutical business to Danaher Corp. He speaks with Bloomberg's Caroline Hyde and...
Bloomberg
How Tribeca's Fromhertz Is Trading the XBI
Apr.04 -- On this edition of "Options Insight," Christian Fromhertz of Tribeca Trade Group discusses his options strategywith Bloomberg's Abigail Doolittle on "Bloomberg Markets: The Close."
Bloomberg
Why Blackstone Is Betting on Costly Drug Trials
Apr.26 -- Blackstone Group LP is betting that it can use its considerable financial muscle to succeed where even the biggest drugmakers need help: getting promising medications over the finish line. Bloomberg's Rebecca Spalding reports...
Bloomberg
JPMorgan Sees Pharma M&A ‘Very Active,’ But ‘Different’ in 2020
Jan.14 -- Christopher Schott, senior pharmaceuticals analyst at JPMorgan, discusses the outlook for M&A deals in the pharmaceutical and biotech industries. He speaks on the sidelines of the JPMorgan Healthcare Conference on "Bloomberg...
Bloomberg
M&G Investments Sees Opportunities in Japan, Korea in 2021
Dec.30 -- Vikas Pershad, fund manager at M&G Investments, discusses his outlook for Asian markets in 2021 and where he’s finding opportunity. He speaks on “Bloomberg Markets: Asia.”